SAVA FY 2021 Earnings — Cassava Sciences, Inc. Revenue & Financial Results | Market Cap Arena

SAVACassava Sciences, Inc.

$115M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$33M

Net Income

-$32M

EPS (Diluted)

$-0.81

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$52M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$267M

Total Liabilities

$13M

Stockholders' Equity

$254M

Cash & Equivalents

$233M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$3M	+100.0%
Operating Income	-$33M	-$6M	-409.9%
Net Income	-$32M	-$6M	-411.3%